335810 fundamentals

Precision Biosensor, Inc. engages in the provision of solutions for Point-of-care Testing (POCT) through the development and commercialization of biomarker diagnostic products. Its products include Exdia TRF Plus, an immunodiagnosis POCT platform that enhances sensitivity based on TRF technology, and Exdia PT10 and Exdia PT10S, a clinical chemistry POCT platform that provides all-in-one diagnostic service based on multiplex technology. The company was founded on September 28, 2009 and is headquartered in Daejeon, South Korea.